<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">TCM</journal-id><journal-title-group><journal-title>Traditional Chinese Medicine</journal-title></journal-title-group><issn pub-type="epub">2166-6067</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.12677/TCM.2017.63026</article-id><article-id pub-id-type="publisher-id">TCM-21359</article-id><article-categories><subj-group subj-group-type="heading"><subject>TCM20170300000_77273164.pdf</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>医药卫生</subject></subj-group></article-categories><title-group><article-title>
 
 
  胆宁片及其主要药效成分代谢药理学研究进展
  Progress in Research on Metabolism and Pharmacology of Danning Tablets and Its Main Pharmacodynamics
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>黄</surname><given-names>杰</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>尤</surname><given-names>圣富</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>杨</surname><given-names>铭</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>郑</surname><given-names>培永</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>季</surname><given-names>光</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>上海中医药大学附属龙华医院，上海</addr-line></aff><aff id="aff1"><addr-line>null</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>yoosf@sina.com(季光)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>13</day><month>06</month><year>2017</year></pub-date><volume>06</volume><issue>03</issue><fpage>160</fpage><lpage>168</lpage><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  胆宁片具有利胆、消炎、防结石等作用，临床上对于慢性胆道感染、胆石症有较好的治疗效果，近年来，胆宁片对非酒精性脂肪肝的疗效和作用逐步被认识，本文对胆宁片及其主要药效成分在糖代谢、脂代谢、胆汁酸代谢方面的调控机制做一概述，以期待其在代谢性疾病领域的研究和应用。
   Danning Tablets which could promote choleresis, reduce inflammation and prevent gallstone, have good therapeutic effects on chronic biliary tract infection and cholelithiasis in clinical practice. In recent years, the treatment of Danning Tablets on nonalcoholic fatty liver disease has gradually been recognized. This passage provides a summary on the regulation mechanism of Danning Tablets and its main components in glucose metabolism, lipid metabolism and bile acid metabolism, and provides the basis for further research and application of Danning Tablets in metabolic related diseases.
   
   
  
 
</p></abstract><kwd-group><kwd>胆宁片，药效成分，代谢，药理学, Danning Tablets</kwd><kwd> Medicinal Composition</kwd><kwd> Metabolism</kwd><kwd> Pharmacology</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>胆宁片及其主要药效成分代谢药理学研究进展<sup> </sup></title><p>黄杰，尤圣富，杨铭，郑培永，季光<sup>*</sup></p><p>上海中医药大学附属龙华医院，上海</p><disp-formula id="hanspub.21359-formula140"><graphic xlink:href="http://html.hanspub.org/file/5-2270216x5_hanspub.png"  xlink:type="simple"/></disp-formula><p>收稿日期：2017年6月28日；录用日期：2017年7月5日；发布日期：2017年7月13日</p><disp-formula id="hanspub.21359-formula141"><graphic xlink:href="http://html.hanspub.org/file/5-2270216x6_hanspub.png"  xlink:type="simple"/></disp-formula></sec><sec id="s2"><title>摘 要</title><p>胆宁片具有利胆、消炎、防结石等作用，临床上对于慢性胆道感染、胆石症有较好的治疗效果，近年来，胆宁片对非酒精性脂肪肝的疗效和作用逐步被认识，本文对胆宁片及其主要药效成分在糖代谢、脂代谢、胆汁酸代谢方面的调控机制做一概述，以期待其在代谢性疾病领域的研究和应用。</p><p>关键词 :胆宁片，药效成分，代谢，药理学</p><disp-formula id="hanspub.21359-formula142"><graphic xlink:href="http://html.hanspub.org/file/5-2270216x7_hanspub.png"  xlink:type="simple"/></disp-formula><p>Copyright &#169; 2017 by authors and Hans Publishers Inc.</p><p>This work is licensed under the Creative Commons Attribution International License (CC BY).</p><p>http://creativecommons.org/licenses/by/4.0/</p><p><img src="http://image.hanspub.org:8080\Html/htmlimages\1-2890033x\e70a10f1-7c93-45ea-9603-062237856e4b.png" /><img src="http://image.hanspub.org:8080\Html\htmlimages\1-2890033x\e898c85e-ffc4-45c9-b817-14224a4d6960.png" /></p></sec><sec id="s3"><title>1. 引言</title><p>胆宁片由大黄、虎杖、青皮、陈皮、郁金、山楂、白茅根7味药材组成，具有利胆、消炎、防结石等作用，临床上对于慢性胆道感染、胆石症有较好的治疗效果 [<xref ref-type="bibr" rid="hanspub.21359-ref1">1</xref>] ，2016年底获加拿大卫生部天然药品和非处方药局批准的上市许可证。近年来，胆宁片对非酒精性脂肪肝的疗效和作用逐步被认识 [<xref ref-type="bibr" rid="hanspub.21359-ref2">2</xref>] - [<xref ref-type="bibr" rid="hanspub.21359-ref9">9</xref>] ，本文对胆宁片及其主要药效成分的代谢药理学作用进行概述，以期待其在代谢性疾病领域的研究和应用。</p></sec><sec id="s4"><title>2. 胆宁片的药物组成及其主要药效成分</title><sec id="s4_1"><title>2.1. 胆宁片的药物组成</title><p>胆宁片由大黄、虎杖、青皮、陈皮、郁金、山楂、白茅根7味中药材组成。</p></sec><sec id="s4_2"><title>2.2. 胆宁片的主要药效成分</title><sec id="s4_2_1"><title>2.2.1. 主要药效成分获取方法</title><p>通过检索数据库获得。检索的靶标数据库：</p><p>HIT(http://lifecenter.sgst.cn/hit/)，</p><p>TCMID(http://www.megabionet.org/tcmid)，</p><p>TCMSP(http://ibts.hkbu.edu.hk/LSP/tcmsp.php)，</p><p>STITCH(http://stitch.embl.de)。</p><p>设定的化合物类药性指数阈值：0.2。</p></sec><sec id="s4_2_2"><title>2.2.2. 主要药效成分检索结果</title><p>检索获得主要药效成分活性化合物结果显示：郁金含有25个活性化合物，陈皮含有20个活性化合物，大黄含有16个活性化合物，虎杖含有17个活性化合物，白茅根含有9个活性化合物，青皮含有8个活性化合物，山楂含有3个活性化合物。不同中药存在部分相同化合物编码，剔除重复部分，共计70个活性化合物。详见表1。</p></sec></sec></sec><sec id="s5"><title>3. 代谢药理学研究进展</title><sec id="s5_1"><title>3.1. 胆宁片中成药的代谢药理学研究进展</title><sec id="s5_1_1"><title>3.1.1. 胆汁酸代谢的调控机制</title><p>胆宁片上调NTCP、MRP3、GSTA1、UGT1A1和MDR2的表达，减少胆汁酸在肝脏中的蓄积，有</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Summary of retrieval results for bioactive compounds from seven kinds of Chinese herbs contained in Danning Tablet</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >序号(No)</th><th align="center" valign="middle" >中药名(Herb)</th><th align="center" valign="middle" >化合物编码(CID)</th><th align="center" valign="middle" >化合物英文名称(ChemName)</th><th align="center" valign="middle" >化合物中文名称(ChemName in Chinese)</th></tr></thead><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >郁金</td><td align="center" valign="middle" >c196</td><td align="center" valign="middle" >vanillic acid</td><td align="center" valign="middle" >香草酸</td></tr><tr><td align="center" valign="middle" >2</td><td align="center" valign="middle" >郁金</td><td align="center" valign="middle" >c27</td><td align="center" valign="middle" >CAM</td><td align="center" valign="middle" >右旋樟脑</td></tr><tr><td align="center" valign="middle" >3</td><td align="center" valign="middle" >郁金</td><td align="center" valign="middle" >c14</td><td align="center" valign="middle" >L-Limonen</td><td align="center" valign="middle" >l-苎烯</td></tr><tr><td align="center" valign="middle" >4</td><td align="center" valign="middle" >郁金</td><td align="center" valign="middle" >c30</td><td align="center" valign="middle" >farnesol</td><td align="center" valign="middle" >金合欢醇</td></tr><tr><td align="center" valign="middle" >5</td><td align="center" valign="middle" >郁金</td><td align="center" valign="middle" >c174</td><td align="center" valign="middle" >eugenol</td><td align="center" valign="middle" >丁子香酚</td></tr><tr><td align="center" valign="middle" >6</td><td align="center" valign="middle" >郁金</td><td align="center" valign="middle" >c31</td><td align="center" valign="middle" >o-Thymol</td><td align="center" valign="middle" >香芹酚</td></tr><tr><td align="center" valign="middle" >7</td><td align="center" valign="middle" >郁金</td><td align="center" valign="middle" >c122</td><td align="center" valign="middle" >beta-sitosterol</td><td align="center" valign="middle" >β-谷甾醇</td></tr><tr><td align="center" valign="middle" >8</td><td align="center" valign="middle" >郁金</td><td align="center" valign="middle" >c536</td><td align="center" valign="middle" >Caffeate</td><td align="center" valign="middle" >咖啡酸酯</td></tr><tr><td align="center" valign="middle" >9</td><td align="center" valign="middle" >郁金</td><td align="center" valign="middle" >c132</td><td align="center" valign="middle" >DBP</td><td align="center" valign="middle" >邻苯二甲酸二丁酯</td></tr><tr><td align="center" valign="middle" >10</td><td align="center" valign="middle" >郁金</td><td align="center" valign="middle" >c534</td><td align="center" valign="middle" >Nerol</td><td align="center" valign="middle" >橙花醇</td></tr><tr><td align="center" valign="middle" >11</td><td align="center" valign="middle" >郁金</td><td align="center" valign="middle" >c467</td><td align="center" valign="middle" >p-coumaric acid</td><td align="center" valign="middle" >对香豆酸</td></tr><tr><td align="center" valign="middle" >12</td><td align="center" valign="middle" >郁金</td><td align="center" valign="middle" >c177</td><td align="center" valign="middle" >beta-elemene</td><td align="center" valign="middle" >β-榄香烯</td></tr><tr><td align="center" valign="middle" >13</td><td align="center" valign="middle" >郁金</td><td align="center" valign="middle" >c681</td><td align="center" valign="middle" >Germacron</td><td align="center" valign="middle" >大根香叶酮</td></tr><tr><td align="center" valign="middle" >14</td><td align="center" valign="middle" >郁金</td><td align="center" valign="middle" >c48</td><td align="center" valign="middle" >cinnamaldehyde</td><td align="center" valign="middle" >肉桂醛</td></tr><tr><td align="center" valign="middle" >15</td><td align="center" valign="middle" >郁金</td><td align="center" valign="middle" >c391</td><td align="center" valign="middle" >m-xylene</td><td align="center" valign="middle" >间二甲苯</td></tr><tr><td align="center" valign="middle" >16</td><td align="center" valign="middle" >郁金</td><td align="center" valign="middle" >c789</td><td align="center" valign="middle" >Cedar acid</td><td align="center" valign="middle" >雪松酸</td></tr><tr><td align="center" valign="middle" >17</td><td align="center" valign="middle" >郁金</td><td align="center" valign="middle" >c2876</td><td align="center" valign="middle" >MBP</td><td align="center" valign="middle" >邻苯二甲酸单丁酯</td></tr><tr><td align="center" valign="middle" >18</td><td align="center" valign="middle" >郁金</td><td align="center" valign="middle" >c4209</td><td align="center" valign="middle" >Zerumbone</td><td align="center" valign="middle" >球姜酮</td></tr><tr><td align="center" valign="middle" >19</td><td align="center" valign="middle" >郁金</td><td align="center" valign="middle" >c1031</td><td align="center" valign="middle" >naringenin</td><td align="center" valign="middle" >柚皮素</td></tr><tr><td align="center" valign="middle" >20</td><td align="center" valign="middle" >郁金</td><td align="center" valign="middle" >c3218</td><td align="center" valign="middle" >ar-turmerone</td><td align="center" valign="middle" >AR-姜黄酮</td></tr><tr><td align="center" valign="middle" >21</td><td align="center" valign="middle" >郁金</td><td align="center" valign="middle" >c1453</td><td align="center" valign="middle" >tetramethylpyrazine</td><td align="center" valign="middle" >川芎嗪</td></tr><tr><td align="center" valign="middle" >22</td><td align="center" valign="middle" >郁金</td><td align="center" valign="middle" >c2763</td><td align="center" valign="middle" >demethoxycurcumin</td><td align="center" valign="middle" >去甲氧基姜黄素</td></tr><tr><td align="center" valign="middle" >23</td><td align="center" valign="middle" >郁金</td><td align="center" valign="middle" >c2766</td><td align="center" valign="middle" >aniline</td><td align="center" valign="middle" >苯胺</td></tr><tr><td align="center" valign="middle" >24</td><td align="center" valign="middle" >郁金</td><td align="center" valign="middle" >c2767</td><td align="center" valign="middle" >curcumin</td><td align="center" valign="middle" >姜黄素</td></tr><tr><td align="center" valign="middle" >25</td><td align="center" valign="middle" >郁金</td><td align="center" valign="middle" >c2768</td><td align="center" valign="middle" >curcumine</td><td align="center" valign="middle" >姜黄素</td></tr><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >陈皮</td><td align="center" valign="middle" >c628</td><td align="center" valign="middle" >DIBP</td><td align="center" valign="middle" >邻苯二甲酸二异丁酯</td></tr><tr><td align="center" valign="middle" >2</td><td align="center" valign="middle" >陈皮</td><td align="center" valign="middle" >c31</td><td align="center" valign="middle" >o-Thymol</td><td align="center" valign="middle" >邻麝香草酚</td></tr><tr><td align="center" valign="middle" >3</td><td align="center" valign="middle" >陈皮</td><td align="center" valign="middle" >c199</td><td align="center" valign="middle" >vanillin</td><td align="center" valign="middle" >香兰素</td></tr><tr><td align="center" valign="middle" >4</td><td align="center" valign="middle" >陈皮</td><td align="center" valign="middle" >c305</td><td align="center" valign="middle" >OYA</td><td align="center" valign="middle" >辛醛</td></tr><tr><td align="center" valign="middle" >5</td><td align="center" valign="middle" >陈皮</td><td align="center" valign="middle" >c537</td><td align="center" valign="middle" >HMF</td><td align="center" valign="middle" >5-羟甲基糠醛</td></tr><tr><td align="center" valign="middle" >6</td><td align="center" valign="middle" >陈皮</td><td align="center" valign="middle" >c467</td><td align="center" valign="middle" >p-coumaric acid</td><td align="center" valign="middle" >对香豆酸</td></tr><tr><td align="center" valign="middle" >7</td><td align="center" valign="middle" >陈皮</td><td align="center" valign="middle" >c1349</td><td align="center" valign="middle" >Antioxidant No. 33</td><td align="center" valign="middle" >抗氧化剂No.33</td></tr><tr><td align="center" valign="middle" >8</td><td align="center" valign="middle" >陈皮</td><td align="center" valign="middle" >c1250</td><td align="center" valign="middle" >DEP</td><td align="center" valign="middle" >邻苯二甲酸二乙酯</td></tr><tr><td align="center" valign="middle" >9</td><td align="center" valign="middle" >陈皮</td><td align="center" valign="middle" >c1031</td><td align="center" valign="middle" >naringenin</td><td align="center" valign="middle" >柚皮素</td></tr></tbody></table></table-wrap><p>表1. 胆宁片7味中药的药效成分活性化合物检索结果汇总</p><p>Continued</p><p>Continued</p><p>效改善胆管结扎小鼠的胆汁瘀积、肝功能及减轻病理损害 [<xref ref-type="bibr" rid="hanspub.21359-ref10">10</xref>] 。</p><p>胆宁片显著减弱易位多药耐药相关蛋白2(MRP2)从细胞膜进入细胞内，上调肝脏代谢酶mRNA和蛋白的表达，包括细胞色素P450 2B1(CYP2B1)和尿苷diphosphate-5分-葡萄糖醛酸基转移酶(UGT1A1))和转运蛋白包括胆盐输出泵(BSEP)和多药耐药相关蛋白2(mdr2))以及肾有机溶质转运蛋白β(ostbeta)，使尿和胆道胆汁酸和胆红素的排泄增加 [<xref ref-type="bibr" rid="hanspub.21359-ref11">11</xref>] 。</p><p>胆宁片的一种主要化合物姜黄素通过法尼醇X受体(FXR)调节胆汁酸和炎症的信号通路，保护α-萘基异硫氰酸酯(ANIT)诱发的胆汁郁积 [<xref ref-type="bibr" rid="hanspub.21359-ref12">12</xref>] 。</p></sec><sec id="s5_1_2"><title>3.1.2. 脂质代谢的调控机制</title><p>胆宁片上调肝细胞CYP7AlmRNA的表达，促进肝脏内胆固醇合成为胆汁酸，防止胆固醇的过度累积，并且下调肝细胞CYP2ElmRNA的表达，从而减轻脂肪变性并增强肝细胞抗氧化能力 [<xref ref-type="bibr" rid="hanspub.21359-ref13">13</xref>] 。</p></sec></sec><sec id="s5_2"><title>3.2. 胆宁片药效成分的代谢药理学研究进展</title><sec id="s5_2_1"><title>3.2.1. 对糖代谢的调控机制</title><p>1) 调控糖原合成</p><p>姜黄素 [<xref ref-type="bibr" rid="hanspub.21359-ref14">14</xref>] 通过cAMP/PKA途径减轻内质网应激，降低脂肪组织分解，阻断游离脂肪酸转运减少游离脂肪酸流入到肝脏，从而提高胰岛素敏感性，抑制肝葡萄糖生产。</p><p>2) 调控糖原代谢</p><p>白藜芦醇 [<xref ref-type="bibr" rid="hanspub.21359-ref15">15</xref>] 激活SIRT1机制，诱导关键转录因子PDX-1和HNF-1的上调，从而促进GLUT2和代谢酶的表达，增强INS-1E细胞和人胰岛中葡萄糖刺激的胰岛素分泌、葡萄糖代谢和胰岛素分泌细胞线粒体活性。白藜芦醇 [<xref ref-type="bibr" rid="hanspub.21359-ref16">16</xref>] 显着上调肝脏Sirt1水平，并抑制肝脏中的InsR和Glut2表达，此外还激活磷脂酰肌醇-4,5-二磷酸3-激酶(PI3K)和AKT的磷酸化，减轻大鼠间歇性缺氧诱导的胰岛素抵抗。白藜芦醇 [<xref ref-type="bibr" rid="hanspub.21359-ref17">17</xref>] 升高肝脏中雷帕霉素、胰岛素受体底物1和磷酸化AKT水平，增加骨骼肌中Glut4，对肝脏和骨骼肌中的葡萄糖代谢途径产生积极影响。白藜芦醇 [<xref ref-type="bibr" rid="hanspub.21359-ref18">18</xref>] 通过激活AMPK来缓解小鼠妊娠期糖尿病症状，从而降低妊娠小鼠及其后代中葡萄糖-6-磷酸酶的产生和活性。</p><p>5-羟色胺 [<xref ref-type="bibr" rid="hanspub.21359-ref19">19</xref>] 以胰岛素协同方式调节肝脏6-磷酸果糖-1-激酶，控制肝糖酵解的能力。</p><p>大黄酸 [<xref ref-type="bibr" rid="hanspub.21359-ref20">20</xref>] 通过阻断高血糖诱导的Drp1表达来保护胰腺β细胞免于细胞凋亡。</p><p>大黄素 [<xref ref-type="bibr" rid="hanspub.21359-ref21">21</xref>] 选择性地抑制1型11β-羟类固醇脱氢酶，降低血糖和肝酶以及葡萄糖-6-磷酸酶mRNA，改善饮食诱导的肥胖小鼠的代谢紊乱。</p><p>槲皮素 [<xref ref-type="bibr" rid="hanspub.21359-ref22">22</xref>] [<xref ref-type="bibr" rid="hanspub.21359-ref23">23</xref>] 通过Akt和AMPK的两个独立的信号通路，显示出改善骨骼肌细胞葡萄糖摄取和胰岛素敏感性的作用。</p><p>香草酸 [<xref ref-type="bibr" rid="hanspub.21359-ref24">24</xref>] 可以通过改善肝胰岛素信号途径来改善胰岛素抵抗。</p></sec><sec id="s5_2_2"><title>3.2.2. 对脂代谢的调控机制</title><p>1) 调控脂质合成</p><p>姜黄素 [<xref ref-type="bibr" rid="hanspub.21359-ref25">25</xref>] 抑制3T3-L1脂肪细胞分化，引起细胞凋亡，抑制脂肪组织中血管生成，从而减少脂肪合成。</p><p>木犀草素 [<xref ref-type="bibr" rid="hanspub.21359-ref26">26</xref>] 通过降低SREBP-2的表达和核移位来调节HMGCR转录，从而降低血液中的胆固醇合成。</p><p>柚皮素 [<xref ref-type="bibr" rid="hanspub.21359-ref27">27</xref>] 激活PPARalpha和PPARgamma脂肪酸氧化基因，同时抑制lxralpha脂肪生成基因，致在原代大鼠肝细胞中的脂肪酸氧化增加，而胆固醇和胆汁酸产量减少。</p><p>β-谷甾醇 [<xref ref-type="bibr" rid="hanspub.21359-ref28">28</xref>] 干扰胶束胆固醇的摄取，导致较少的血浆膜胆固醇进入和较少的胆固醇酯被分泌，降低了HMG-CoA还原酶基因表达水平的胆固醇合成。</p><p>白藜芦醇 [<xref ref-type="bibr" rid="hanspub.21359-ref29">29</xref>] 提高了SIRT1的表达水平，明显增加循环脂联素水平和肝脂联素受体(AdipoR1/R2)的mRNA表达，导致脂质合成减少。白藜芦醇 [<xref ref-type="bibr" rid="hanspub.21359-ref30">30</xref>] 提高SIRT1的表达，抑制ACC，PPAR-γ和SREBP-1 mRNA表达，减少脂肪生成。</p><p>槲皮素 [<xref ref-type="bibr" rid="hanspub.21359-ref31">31</xref>] 在血清中的浓度范围内能抑制脂肪的生成，但需要更高的剂量(至少10 μm每天)以减少成熟脂肪细胞中的脂肪积累。1 μm每天的槲皮素降低C/EBPbeta基因表达、SREBP1成熟蛋白水平和PPARgamma基因表达，10 μm每天的槲皮素降低LPL基因表达和PPARgamma和SREBP1c表达。在成熟脂肪细胞中，只有10 μm每天的槲皮素使脂质FAS表达和活性减少，降低甘油三酯含量。</p><p>2) 调控脂质转运</p><p>姜黄素 [<xref ref-type="bibr" rid="hanspub.21359-ref14">14</xref>] 抑制脂肪组织的内质网应激所需肌醇酶1α和真核起始因子2α磷酸化，并通过保留磷酸二酯酶3B诱导来减少cAMP积聚，由于cAMP的下调阻断蛋白激酶(PK)A/激素敏感性脂肪酶脂肪分解信号，从而降低脂肪组织中的甘油和游离脂肪酸释放。姜黄素 [<xref ref-type="bibr" rid="hanspub.21359-ref32">32</xref>] 通过Nrf2/FXR激活依赖性机制调节肝细胞脂质沉积来减弱酒精性肝病。</p><p>白藜芦醇 [<xref ref-type="bibr" rid="hanspub.21359-ref33">33</xref>] 在肌肉中激活AMPK，增加SIRT1和PGC-1alpha蛋白水平，增加柠檬酸合酶活性而线粒体含量没有变化，并改善脂肪酸衍生底物上的肌肉线粒体呼吸。从而升高肌内细胞脂质水平，降低肝内脂质含量、循环葡萄糖、甘油三酯、丙氨酸氨基转移酶和炎症标志物。</p><p>槲皮素 [<xref ref-type="bibr" rid="hanspub.21359-ref34">34</xref>] 显著抑制TXNIP表达、NLRP3炎症细胞活化，下调PPARα和上调固醇调节元件结合蛋白-1c调节(SREBP-1c)、SREBP-2、脂肪酸合酶和肝X受体α，以及糖尿病大鼠肝脏ROS和IL-1β的升高，有助于抑制肝脏炎症和高血糖条件下脂质积累的减少，对1型糖尿病相关的非酒精性脂肪肝有预防和治疗作用。</p><p>3) 调控脂质代谢</p><p>姜黄素 [<xref ref-type="bibr" rid="hanspub.21359-ref35">35</xref>] 通过TCA循环、糖酵解和糖异生、酮体和胆固醇合成、支链氨基酸、胆碱代谢酮体生成和脂肪酸代谢通路，恢复高脂饮食诱导的小鼠高脂血症。姜黄素 [<xref ref-type="bibr" rid="hanspub.21359-ref36">36</xref>] 通过AMPK活化调节肝脏脂质代谢来减弱高脂肪/胆固醇饮食诱导的肝脂肪变性。</p><p>对香豆酸 [<xref ref-type="bibr" rid="hanspub.21359-ref37">37</xref>] 通过AMPK激活途径调节HepG2细胞中的脂质代谢。</p><p>白藜芦醇 [<xref ref-type="bibr" rid="hanspub.21359-ref29">29</xref>] 提高了SIRT1的表达水平，并刺激了乙醇饲喂小鼠肝脏的AMPK活性，明显增加循环脂联素水平和肝脂联素受体(AdipoR1/R2)的mRNA表达，导致脂质合成减少，脂肪酸氧化速率增加，并阻止酒精性肝脂肪变性。</p></sec><sec id="s5_2_3"><title>3.2.3. 对胆汁酸代谢的调控机制</title><p>柚皮素 [<xref ref-type="bibr" rid="hanspub.21359-ref27">27</xref>] 激活PPARalpha和PPARgamma脂肪酸氧化基因，同时抑制lxralpha脂肪生成基因，致在原代大鼠肝细胞中的脂肪酸氧化增加，而胆固醇和胆汁酸产量减少。</p></sec></sec></sec><sec id="s6"><title>4. 小结与展望</title><p>综上所述，胆宁片除治疗慢性胆道感染、胆石症外，对代谢性疾病的作用也逐渐被认识，胆宁片的应用前景非常广阔。目前而言，随着胆宁片的澳洲上市，其治疗非酒精性脂肪肝的作用对于西方高脂饮食人群而言其市场极其广阔，然而对于复方的作用机制研究并不是很清楚，很多工作知识停留在药效学方面，其改善代谢紊乱有可能是通过多个靶点来发挥作用的，下一步的工作有必要加以阐明。</p></sec><sec id="s7"><title>基金项目</title><p>上海卫生三年行动计划(No. ZY3-CCCX-2-1002, ZY3-CCCX-3-4001)。</p></sec><sec id="s8"><title>文章引用</title><p>黄杰,尤圣富,杨铭,郑培永,季光. 胆宁片及其主要药效成分代谢药理学研究进展Progress in Research on Metabolism and Pharmacology of Danning Tablets and Its Main Pharmacodynamics[J]. 中医学, 2017, 06(03): 160-168. http://dx.doi.org/10.12677/TCM.2017.63026</p></sec><sec id="s9"><title>参考文献 (References)</title></sec></body><back><ref-list><title>References</title><ref id="hanspub.21359-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">曹晖. 胆宁片临床研究进展[J]. 上海医药, 2007, 28(5): 222-223.</mixed-citation></ref><ref id="hanspub.21359-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">高鹰, 周颖. 胆宁片联合多烯磷脂酰胆碱胶囊治疗非酒精性脂肪肝的疗效观察[J]. 现代药物与临床, 2017, 32(3): 464-467.</mixed-citation></ref><ref id="hanspub.21359-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">盛潇磊, 袁睿, 蔺汝云. 胆宁片预防性治疗复发性高甘油三脂血症性胰腺炎合并脂肪肝22例临床分析[J]. 云南中医中药杂志, 2016, 37(4): 85-87.</mixed-citation></ref><ref id="hanspub.21359-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">彭丽瑞, 马利平. 胆宁片联合瑞舒伐他汀治疗非酒精性脂肪肝病的疗效观察[J]. 世界最新医学信息文摘(连续型电子期刊), 2015, 15(16): 110.</mixed-citation></ref><ref id="hanspub.21359-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">王志凌. 胆宁片治疗非酒精性脂肪肝病的疗效观察[J]. 中国医药指南, 2014, 12(23): 158-159.</mixed-citation></ref><ref id="hanspub.21359-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">冯艳. 胆宁片联合辛伐他汀治疗非酒精性脂肪肝的临床观察[J]. 中国医药指南, 2013, 11(9): 640-641.</mixed-citation></ref><ref id="hanspub.21359-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">阙一平, 周瑞芳. 胆宁片治疗非酒精性脂肪肝32例疗效观察[J]. 中国社区医师(医学专业), 2011, 13(8): 121.</mixed-citation></ref><ref id="hanspub.21359-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">吕清国. 胆宁片治疗非酒精性脂肪肝安全性和有效性临床研究(肝气郁滞、湿热内蕴证研究) [D]: [硕士学位论文]. 2009: 1-36.</mixed-citation></ref><ref id="hanspub.21359-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">芮铭安, 王曹锋, 方晶, 等. 还原型谷胱甘肽和胆宁片治疗非酒精性脂肪肝的临床疗效对比[J]. 中国全科医学, 2001(4): 269-270.</mixed-citation></ref><ref id="hanspub.21359-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">王莉, 丁丽丽, 杨帆, 等. 胆宁片对胆汁瘀积小鼠肝脏转运体及代谢酶基因表达的影响[J]. 中成药, 2013(7): 1385-1389.</mixed-citation></ref><ref id="hanspub.21359-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Ding, L., Zhang, B., Zhan, C., et al. (2014) Danning Tablets Attenuates α-Naphthylisothiocyanate-Induced Cholestasis by Modulating the Expression of Transporters and Metabolic Enzymes. BMC Complementary and Alternative Medicine, 14, 249. &lt;br&gt;https://doi.org/10.1186/1472-6882-14-249</mixed-citation></ref><ref id="hanspub.21359-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Yang, F., Tang, X., Ding, L., et al. (2016) Curcumin Protects ANIT-Induced Cholestasis through Signaling Pathway of FXR-Regulated Bile Acid and Inflammation. Scientific Reports, 6, Article No. 33052.  
&lt;br&gt;https://doi.org/10.1038/srep33052</mixed-citation></ref><ref id="hanspub.21359-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">陈鹏. 胆宁片对非酒精性脂肪肝新西兰兔脂代谢影响的实验研究[D]: [硕士学位论文]. 南京: 南京中医药大学, 2014: 17-29.</mixed-citation></ref><ref id="hanspub.21359-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Wang, L., Zhang, B., Huang, F., et al. (2016) Curcumin Inhibits Lipolysis via Suppression of ER Stress in Adipose Tissue and Prevents Hepatic Insulin Resistance. Journal of Lipid Research, 57, 1243-1255. 
&lt;br&gt;https://doi.org/10.1194/jlr.M067397</mixed-citation></ref><ref id="hanspub.21359-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Vetterli, L., Brun, T., Giovannoni, L., et al. (2011) Resveratrol Potentiates Glucose-Stimulated Insulin Secretion in INS-1E Beta-Cells and Human Islets through a SIRT1-Dependent Mechanism. Journal of Biological Chemistry, 286, 6049-6060. &lt;br&gt;https://doi.org/10.1074/jbc.M110.176842</mixed-citation></ref><ref id="hanspub.21359-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Wang, Q., Sun, X., Li, X., et al. (2015) Resveratrol Attenuates Intermittent Hypoxia-Induced Insulin Resistance in Rats: Involvement of Sirtuin 1 and the Phosphatidylinositol-4,5-Bisphosphate 3-Kinase/AKT Pathway. Molecular Medicine Reports, 11, 151-158.</mixed-citation></ref><ref id="hanspub.21359-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Burgess, T.A., Robich, M.P., Chu, L.M., et al. (2011) Improving Glucose Metabolism with Resveratrol in a Swine Model of Metabolic Syndrome through Alteration of Signaling Pathways in the Liver and Skeletal Muscle. Archives of Surgery, 146, 556-564. &lt;br&gt;https://doi.org/10.1001/archsurg.2011.100</mixed-citation></ref><ref id="hanspub.21359-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Yao, L., Wan, J., Li, H., et al. (2015) Resveratrol Relieves Gestational Diabetes Mellitus in Mice through Activating AMPK. Reproductive Biology and Endocrinology, 13, 118. &lt;br&gt;https://doi.org/10.1186/s12958-015-0114-0</mixed-citation></ref><ref id="hanspub.21359-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Coelho, W.S., Da Silva, D., Marinho-Carvalho, M.M. and Sola-Penna, M. (2012) Serotonin Modulates Hepatic 6- Phosphofructo-1-Kinase in an Insulin Synergistic Manner. The International Journal of Biochemistry &amp; Cell Biology, 44, 150-157.</mixed-citation></ref><ref id="hanspub.21359-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Liu, J., et al. (2013) Rhein Protects Pancreatic β-Cells From Dynamin-Related Protein-1-Mediated Mitochondrial Fission and Cell Apoptosis under Hyperglycemia. Diabetes, 62, 3927-3935. &lt;br&gt;https://doi.org/10.2337/db13-0251</mixed-citation></ref><ref id="hanspub.21359-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Feng, Y., et al. (2010) Emodin, a Natural Product, Selectively Inhibits 11β-Hydroxysteroid Dehydrogenase Type 1 and Ameliorates Metabolic Disorder in Diet-Induced Obese Mice. British Journal of Pharmacology, 161, 113-126. 
&lt;br&gt;https://doi.org/10.1111/j.1476-5381.2010.00826.x</mixed-citation></ref><ref id="hanspub.21359-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Dai, X., Ding, Y., Zhang, Z., et al. (2013) Quercetin but Not Quercitrin Ameliorates Tumor Necrosis Factor-Alpha- Induced Insulin Resistance in C2C12 Skeletal Muscle Cells. Biological and Pharmaceutical Bulletin, 36, 788-795. 
&lt;br&gt;https://doi.org/10.1248/bpb.b12-00947</mixed-citation></ref><ref id="hanspub.21359-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Eid, H.M., Nachar, A., Thong, F., et al. (2015) The Molecular Basis of the Antidiabetic Action of Quercetin in Cultured Skeletal Muscle Cells and Hepatocytes. Pharmacognosy Magazine, 11, 74-81.  
&lt;br&gt;https://doi.org/10.4103/0973-1296.149708</mixed-citation></ref><ref id="hanspub.21359-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Chang, W.-C., et al. (2015) Protective Effect of Vanillic Acid against Hyperinsulinemia, Hyperglycemia and Hyperlipidemia via Alleviating Hepatic Insulin Resistance and Inflammation in High-Fat Diet (HFD)-Fed Rats. Nutrients, 7, 9946-9959. &lt;br&gt;https://doi.org/10.3390/nu7125514</mixed-citation></ref><ref id="hanspub.21359-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Ejaz, A., Wu, D., Kwan, P. and Meydani, M. (2009) Curcumin Inhibits Adipogenesis in 3T3-L1 Adipocytes and Angiogenesis and Obesity in C57/BL Mice. Journal of Nutrition, 139, 919-925. &lt;br&gt;https://doi.org/10.3945/jn.108.100966</mixed-citation></ref><ref id="hanspub.21359-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Wong, T.Y., Lin, S.-M. and Leung, L.K. (2015) The Flavone Luteolin Suppresses SREBP-2 Expression and Post- Translational Activation in Hepatic Cells. PLoS ONE, 10, e135637. &lt;br&gt;https://doi.org/10.1371/journal.pone.0135637</mixed-citation></ref><ref id="hanspub.21359-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Goldwasser, J., Cohen, P.Y., Yang, E., et al. (2010) Transcriptional Regulation of Human and Rat Hepatic Lipid Metabolism by the Grapefruit Flavonoid Naringenin: Role of PPARα, PPARγ and LXRα. PLoS ONE, 5, e12399.  
&lt;br&gt;https://doi.org/10.1371/journal.pone.0012399</mixed-citation></ref><ref id="hanspub.21359-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Field, F.J., Born, E. and Mathur, S.N. (1997) Effect of Micellar β-Sitosterol on Cholesterol Metabolism in CaCo-2 Cells. Journal of Lipid Research, 38, 348-360.</mixed-citation></ref><ref id="hanspub.21359-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Ajmo, J.M., Liang, X., Rogers, C.Q., et al. (2008) Resveratrol Alleviates Alcoholic Fatty Liver in Mice. The American Journal of Physiology-Gastrointestinal and Liver Physiology, 295, G833-G842.  
&lt;br&gt;https://doi.org/10.1152/ajpgi.90358.2008</mixed-citation></ref><ref id="hanspub.21359-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Andrade, J.M., Paraiso, A.F., de Oliveira, M.V., et al. (2014) Resveratrol Attenuates Hepatic Steatosis in High-Fat Fed Mice by Decreasing Lipogenesis and Inflammation. Nutrition, 30, 915-919. &lt;br&gt;https://doi.org/10.1016/j.nut.2013.11.016</mixed-citation></ref><ref id="hanspub.21359-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Eseberri, I., Miranda, J., Lasa, A., et al. (2015) Doses of Quercetin in the Range of Serum Concentrations Exert Delipidating Effects in 3T3-L1 Preadipocytes by Acting on Different Stages of Adipogenesis, but Not in Mature Adipocytes. Oxidative Medicine and Cellular Longevity, 2015, Article ID: 480943. &lt;br&gt;https://doi.org/10.1155/2015/480943</mixed-citation></ref><ref id="hanspub.21359-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Lu, C., Zhang, F., Xu, W., et al. (2015) Curcumin Attenuates Ethanol-Induced Hepatic Steatosis through Modulating Nrf2/FXR Signaling in Hepatocytes. IUBMB Life, 67, 645-658. &lt;br&gt;https://doi.org/10.1002/iub.1409</mixed-citation></ref><ref id="hanspub.21359-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Timmers, S., Konings, E., Bilet, L., et al. (2011) Calorie Restriction-Like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans. Cell Metabolism, 14, 612-622. 
&lt;br&gt;https://doi.org/10.1016/j.cmet.2011.10.002</mixed-citation></ref><ref id="hanspub.21359-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Wang, W., Wang, C., Ding, X.Q., et al. (2013) Quercetin and Allopurinol Reduce Liver Thioredoxin-Interacting Protein to Alleviate Inflammation and Lipid Accumulation in Diabetic Rats. British Journal of Pharmacology, 169, 1352- 1371. &lt;br&gt;https://doi.org/10.1111/bph.12226</mixed-citation></ref><ref id="hanspub.21359-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">Li, Z.Y., Ding, L.L., Li, J.M., et al. (2015) 1H-NMR and MS Based Metabolomics Study of the Intervention Effect of Curcumin on Hyperlipidemia Mice Induced by High-Fat Diet. PLoS ONE, 10, e120950. 
&lt;br&gt;https://doi.org/10.1371/journal.pone.0120950</mixed-citation></ref><ref id="hanspub.21359-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">Um, M.Y., Hwang, K.H., Ahn, J. and Ha, T.Y. (2013) Curcumin Attenuates Diet-Induced Hepatic Steatosis by Activating AMP-Activated Protein Kinase. Basic &amp; Clinical Pharmacology &amp; Toxicology, 113, 152-157. 
&lt;br&gt;https://doi.org/10.1111/bcpt.12076</mixed-citation></ref><ref id="hanspub.21359-ref37"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">Kim, J.H., Kang, S.I., Shin, H.S., et al. (2013) Sasa quelpaertensis and p-Coumaric Acid Attenuate Oleic Acid-Induced Lipid Accumulation in HepG2 Cells. Bioscience, Biotechnology, and Biochemistry, 77, 1595-1598. 
&lt;br&gt;https://doi.org/10.1271/bbb.130167</mixed-citation></ref></ref-list></back></article>